Oruka Therapeutics, Inc. ORKA Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period at other companies

RepligenRGEN

0—

LivaNovaLIVN

145.5K-38.4%

SkyWestSKYW

3.8K-60.8%

HTF

Heartflow, Inc. Common StockHTFL

$592.39K+284%

Option Care Health, Inc.OPCH

96K—

BancFirst CorporationBANF

11.1K-47.4%

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, exercises in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, exercises in period?: Oruka Therapeutics, Inc. (ORKA) reported share-based compensation arrangement by share-based payment award, options, exercises in period of 58.6K in Q1 2026.
What does share-based compensation arrangement by share-based payment award, options, exercises in period mean?: The number of common shares issued as a result of employees exercising their vested stock options. This activity directly impacts the total weighted-average shares outstanding and reflects the conversion of incentive compensation into equity ownership.